These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 2478282)
1. Monoclonal antibody targeting of liposomes to mouse lung in vivo. Hughes BJ; Kennel S; Lee R; Huang L Cancer Res; 1989 Nov; 49(22):6214-20. PubMed ID: 2478282 [TBL] [Abstract][Full Text] [Related]
2. Microdistribution of specific rat monoclonal antibodies to mouse tissues and human tumor xenografts. Kennel SJ; Falcioni R; Wesley JW Cancer Res; 1991 Mar; 51(5):1529-36. PubMed ID: 1997194 [TBL] [Abstract][Full Text] [Related]
3. Characterization of in vivo immunoliposome targeting to pulmonary endothelium. Maruyama K; Holmberg E; Kennel SJ; Klibanov A; Torchilin VP; Huang L J Pharm Sci; 1990 Nov; 79(11):978-84. PubMed ID: 2292774 [TBL] [Abstract][Full Text] [Related]
4. Quantitation of a murine lung endothelial cell protein, P112, with a double monoclonal antibody assay. Kennel SJ; Lankford T; Hughes B; Hotchkiss JA Lab Invest; 1988 Nov; 59(5):692-701. PubMed ID: 2460698 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of lung tumor colony formation by treatment of mice with monoclonal antibodies to pulmonary capillary endothelial cells. Kennel SJ; Lankford TK; Ullrich RL; Jamasbi RJ Cancer Res; 1988 Sep; 48(17):4964-8. PubMed ID: 3409228 [TBL] [Abstract][Full Text] [Related]
7. Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol)s conjugated at their distal terminals to monoclonal antibodies. Maruyama K; Takizawa T; Yuda T; Kennel SJ; Huang L; Iwatsuru M Biochim Biophys Acta; 1995 Mar; 1234(1):74-80. PubMed ID: 7880861 [TBL] [Abstract][Full Text] [Related]
8. Characterization of organ-specific immunoliposomes for delivery of 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in a mouse lung-metastasis model. Mori A; Kennel SJ; van Borssum Waalkes M; Scherphof GL; Huang L Cancer Chemother Pharmacol; 1995; 35(6):447-56. PubMed ID: 7882453 [TBL] [Abstract][Full Text] [Related]
9. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxicity of adriamycin-containing immunoliposomes targeted with anti-ganglioside monoclonal antibodies. Ohta S; Igarashi S; Honda A; Sato S; Hanai N Anticancer Res; 1993; 13(2):331-6. PubMed ID: 8517645 [TBL] [Abstract][Full Text] [Related]
11. Lipid composition is important for highly efficient target binding and retention of immunoliposomes. Maruyama K; Kennel SJ; Huang L Proc Natl Acad Sci U S A; 1990 Aug; 87(15):5744-8. PubMed ID: 2377612 [TBL] [Abstract][Full Text] [Related]
13. Pretargeting of carcinoembryonic antigen-expressing tumors with a biologically produced bispecific anticarcinoembryonic antigen x anti-indium-labeled diethylenetriaminepentaacetic acid antibody. van Schaijk FG; Oosterwijk E; Soede AC; Broekema M; Frielink C; McBride WJ; Goldenberg DM; Corstens FH; Boerman OC Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7130s-7136s. PubMed ID: 16203812 [TBL] [Abstract][Full Text] [Related]
14. Use of antibody as carrier of oligomers of peptidomimetic alphavbeta3 antagonist to target tumor-induced neovasculature. Shin IS; Jang BS; Danthi SN; Xie J; Yu S; Le N; Maeng JS; Hwang IS; Li KC; Carrasquillo JA; Paik CH Bioconjug Chem; 2007; 18(3):821-8. PubMed ID: 17375899 [TBL] [Abstract][Full Text] [Related]
15. Targeting of an anti-CR3 (CD11b/CD18) monoclonal antibody to spleen but not brain, in vivo in mice. Skarlatos S; Pardridge WM J Drug Target; 1995; 3(1):9-14. PubMed ID: 7655827 [TBL] [Abstract][Full Text] [Related]
16. Specific targeting and killing activities of anti-P-glycoprotein monoclonal antibody MRK16 directed against intrinsically multidrug-resistant human colorectal carcinoma cell lines in the nude mouse model. Iwahashi T; Okochi E; Ariyoshi K; Watabe H; Amann E; Mori S; Tsuruo T; Ono K Cancer Res; 1993 Nov; 53(22):5475-82. PubMed ID: 8106147 [TBL] [Abstract][Full Text] [Related]
17. Specific binding of TES-23 antibody to tumour vascular endothelium in mice, rats and human cancer tissue: a novel drug carrier for cancer targeting therapy. Tsunoda S; Ohizumi I; Matsui J; Koizumi K; Wakai Y; Makimoto H; Tsutsumi Y; Utoguchi N; Taniguchi K; Saito H; Harada N; Ohsugi Y; Mayumi T Br J Cancer; 1999 Dec; 81(7):1155-61. PubMed ID: 10584876 [TBL] [Abstract][Full Text] [Related]
18. Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature. Muzykantov VR; Barnathan ES; Atochina EN; Kuo A; Danilov SM; Fisher AB J Pharmacol Exp Ther; 1996 Nov; 279(2):1026-34. PubMed ID: 8930213 [TBL] [Abstract][Full Text] [Related]
19. Experimental therapy of human breast tumors with 131I-labeled monoclonal antibodies prepared against the human milk fat globule. Ceriani RL; Blank EW Cancer Res; 1988 Aug; 48(16):4664-72. PubMed ID: 3396015 [TBL] [Abstract][Full Text] [Related]
20. Chelate conjugates of monoclonal antibodies for imaging lymphoid structures in the mouse. Goodwin DA; Meares CF; McCall MJ; Haseman MK; McTigue M; Diamanti CI; Chaovapong W J Nucl Med; 1985 May; 26(5):493-502. PubMed ID: 3921673 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]